|
Volumn 86, Issue 2, 2008, Pages 293-297
|
Inclusion of donor colon and ileocecal valve in intestinal transplantation
b
NONE
(United States)
|
Author keywords
Intestinal transplant; Large bowel; Outcomes
|
Indexed keywords
ALEMTUZUMAB;
DACLIZUMAB;
ADULT;
ARTICLE;
CAUSE OF DEATH;
CHILD;
COLON;
DONOR;
FECES;
GARDNER SYNDROME;
GASTROSCHISIS;
GRAFT FAILURE;
GRAFT RECIPIENT;
GRAFT REJECTION;
GRAFT SURVIVAL;
HIRSCHSPRUNG DISEASE;
HUMAN;
ILEOCECAL VALVE;
IMMUNOSUPPRESSIVE TREATMENT;
INJURY;
INTESTINE ATRESIA;
INTESTINE GRAFT;
INTESTINE PSEUDOOBSTRUCTION;
MAJOR CLINICAL STUDY;
MEGACOLON;
MORBIDITY;
MORTALITY;
NECROTIZING ENTEROCOLITIS;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PROGNOSIS;
RETROSPECTIVE STUDY;
SCHOOL CHILD;
STOMA;
SURGICAL INFECTION;
THROMBOSIS;
VOLVULUS;
ADOLESCENT;
AGED;
FEMALE;
INTESTINE;
MALE;
METHODOLOGY;
MIDDLE AGED;
ORGAN TRANSPLANTATION;
PROPORTIONAL HAZARDS MODEL;
RISK;
TRANSPLANTATION;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
CHILD;
COLON;
FEMALE;
GRAFT SURVIVAL;
HUMANS;
ILEOCECAL VALVE;
INTESTINES;
MALE;
MIDDLE AGED;
ORGAN TRANSPLANTATION;
PROPORTIONAL HAZARDS MODELS;
RISK;
TREATMENT OUTCOME;
|
EID: 49249091186
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/TP.0b013e31817ef01c Document Type: Article |
Times cited : (58)
|
References (7)
|